| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/20/2007 | CN1321694C Freezedrying type vaccine of AIDS recombined poxvirus with Ankara gene stock carrier, and preparation method |
| 06/20/2007 | CN1321693C Over-expressing homologous antigen vaccine and method of making same |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/20/2007 | CN1321684C Method of extracting rainbow conk saccharide peptide for injection in rainbow conk saccharided peptide crude product obtained from submerged fermentation |
| 06/20/2007 | CN1321672C Chinese traditional medicine compound preparation for treating chronic gastritis accompanied with Helicobacter pylori infection |
| 06/20/2007 | CN1321666C Combination of medication of containing astragalus root and dragon's blood resin and application |
| 06/20/2007 | CN1321665C Combination of medication by using beartyberry and dragon's blood resin as combination of activities |
| 06/20/2007 | CN1321652C Chinese traditional medicine composition for resisting Helicobacter pylori, and prepn. method therefor |
| 06/20/2007 | CN1321644C Process for making substituted pyrazoles |
| 06/20/2007 | CN1321633C Treatment of nail infections using NO generating compositions |
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/19/2007 | US7232835 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists |
| 06/19/2007 | US7232834 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor |
| 06/19/2007 | US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 06/19/2007 | US7232814 Heterocyclic carboxy amines such as 9-nitro-7,12-dihydroindolo (3,2-d)(1)-benzazepin-6(5H)-one, used as inhibitors of glycogen synthase kinase-3 beta or cyclin dependent kinases |
| 06/19/2007 | US7232803 Molecule comprising backbone of 2-35 non-hydrogen atoms in length, having covalently attached bulky lipoophilic groups and having more cationic than anionic moiety in manufacturing medicament for destabilising microbial cell membranes |
| 06/19/2007 | US7232800 for a cleavage reagent while preserving the anti-microbial activity; reagent includes alkaline protease such as trypsin and clotrispain; genetic engineering |
| 06/19/2007 | US7232682 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/19/2007 | US7232680 For producing vaccine for protecting a mammal or a bird from infection by a Nidovirales virus |
| 06/19/2007 | US7232564 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 06/19/2007 | US7232563 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects |
| 06/19/2007 | CA2316888C Methods of inactivating bacteria including bacterial spores |
| 06/19/2007 | CA2304624C Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for the corresponding antifungal agent |
| 06/19/2007 | CA2159112C Anti-microbial agents and screening method therefor |
| 06/14/2007 | WO2007068007A1 Use of a disinfectant for treating respiratory tract infections |
| 06/14/2007 | WO2007067416A2 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| 06/14/2007 | WO2007066992A1 Composition comprising an extract of celosia for preventing and treating animal disease caused by viruses |
| 06/14/2007 | WO2007066991A1 Composition comprising an extract of celosia for preventing and treating human disease caused by viruses |
| 06/14/2007 | WO2007066805A1 Lincomycin derivative and antibacterial agent containing the same as active ingredient |
| 06/14/2007 | WO2007065883A1 Antiviral azanucleoside derivatives |
| 06/14/2007 | WO2007065829A1 Antiviral nucleosides |
| 06/14/2007 | WO2007065439A1 Method for generating dendritic cells employing decreased temperature |
| 06/14/2007 | WO2007065372A1 Use of cortex prunus armeniaca l. and extracts thereof in manufacturing medicaments for treating acquired immunodeficiency syndrome |
| 06/14/2007 | WO2007065314A1 Compound preparation for treating virus hepatopathy |
| 06/14/2007 | WO2007065231A2 Azacytosine derivatives useful as antiviral agents |
| 06/14/2007 | WO2007050721A3 Heterocyclic aspartyl protease inhibitors |
| 06/14/2007 | WO2007050375A3 Piperazine derivatives useful as ccr5 antagonists |
| 06/14/2007 | WO2007048848A3 V-atpase inhibitors for use in the treatment of septic shock |
| 06/14/2007 | WO2007048244A3 Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides |
| 06/14/2007 | WO2007017901A3 Silver nanoparticle dispersion formulation |
| 06/14/2007 | WO2006136460A3 New adjuvant |
| 06/14/2007 | WO2006120580A3 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides |
| 06/14/2007 | WO2006109192A3 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 06/14/2007 | WO2006048768A8 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 06/14/2007 | WO2004043335A3 Methods of treating infection by drug resistant bacteria |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135483 Such as 14-O[(N-(3-Methyl-2-amino-buturyl-piperidin-3(S)-yl)sulfanyl)acetyl]mutilin |
| 06/14/2007 | US20070135477 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/14/2007 | US20070135464 Antiinflammation agents |
| 06/14/2007 | US20070135451 Imidazo[1,2-a]Pyridine Derivatives for Treatment Of Herpes Viral Infections |
| 06/14/2007 | US20070135447 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors |
| 06/14/2007 | US20070135422 Nitrogen-containing bicycle heterocycles for use as antibacterials |
| 06/14/2007 | US20070135404 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 06/14/2007 | US20070135381 Derivatives of branch-chain lipophilic molecular and uses thereof |
| 06/14/2007 | US20070135363 For therapy of infectious diseases and proliferative disorders, such as viral infections or cancer |
| 06/14/2007 | US20070135353 Crystalline n-formyl hydroxylamine compounds |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | US20070134693 Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/14/2007 | US20070134270 Chicken rna polymerase i promoter and the use thereof |
| 06/14/2007 | US20070134269 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 06/14/2007 | US20070134262 Polypeptide encoded by an alternative reading frame of a pathogenic virus or a fragment comprising more than 7 amino acids; Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, Hepatitis D virus, Hepatitis E virus, Hepatitis F virus Hepatitis G virus, Human Immunodeficiency virus, Influenza virus |
| 06/14/2007 | US20070134255 Hmpv treatment with ribavirin and anti-hmpv antibody |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | US20070134221 Stabilizing peptides |
| 06/14/2007 | DE19936997B4 Verfahren zur Applikation von Photosensibilisatoren (PS) mittels Multiplikatoren in der photodymamischen Therapie A process for the application of photosensitizers (PS) by means of multipliers in the therapy photodymamischen |
| 06/14/2007 | CA2838111A1 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
| 06/14/2007 | CA2783572A1 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 06/14/2007 | CA2640836A1 Method for generating dendritic cells employing decreased temperature |
| 06/14/2007 | CA2632643A1 Chemical compounds |
| 06/14/2007 | CA2632476A1 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| 06/13/2007 | EP1795593A1 Target nucleic acid of retrovirus integration |
| 06/13/2007 | EP1795206A1 Drug for treating or preventing hcv infection |
| 06/13/2007 | EP1795197A1 Pharmaceutical compositions comprising an antibiotic |
| 06/13/2007 | EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors |
| 06/13/2007 | EP1795181A1 Cosmetic and pharmaceutical uses of the dipeptide tyrosine-arginine in combination with niacinamide as substance P antagonist |
| 06/13/2007 | EP1794187A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 06/13/2007 | EP1794179A1 Ring-closing metathesis process in supercritical fluid |
| 06/13/2007 | EP1794178A1 Process for preparing macrocyclic hcv protease inhibitors |
| 06/13/2007 | EP1794172A1 Antiviral 4'-azido-nucleosides |
| 06/13/2007 | EP1794167A1 Substituted isoxazoles as fungicides |
| 06/13/2007 | EP1794152A1 Method for manufacturing enantiomeric imidazole compounds |
| 06/13/2007 | EP1794142A1 A novel compound and a novel microorganism for producing the novel compound |
| 06/13/2007 | EP1793848A1 Method for determining dosage for an oral killed vaccine |
| 06/13/2007 | EP1793846A1 Compositions and methods comprising vitamin b12 and an impdh inhibitor for treating viral, inflammatory and proliferative diseases |
| 06/13/2007 | EP1793844A1 Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3-[etval]4-cyclosporin |
| 06/13/2007 | EP1793837A2 Fatty acid modified polylysines as antimicrobial agents |
| 06/13/2007 | EP1793825A2 Chemcial compounds |
| 06/13/2007 | EP1793819A2 Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1429795B1 Method for producing extracts of pelargonium sidoides and/or pelargonium reniforme |
| 06/13/2007 | EP1387844B1 Retinol derivatives potentiation of active substances by micellar preparation |
| 06/13/2007 | EP1357944B1 Perylenequinones for use with immunotherapy agents |
| 06/13/2007 | EP1330425B1 C-nitroso compounds and use thereof |
| 06/13/2007 | EP1326611B1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| 06/13/2007 | EP1267925B1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
| 06/13/2007 | EP1244690B1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1037909B1 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/13/2007 | EP1012304B1 Component of bromelain |
| 06/13/2007 | EP0975354B1 Ligand/lytic peptide compositions and methods of use |